"Our Dallas clinical research center is one of the most respected & sought-after locations in North Texas, specializing in infectious disease research."

During the past decade, North Texas Infectious Diseases Consultants conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 25 clinical trials were completed, i.e. on average, 80.6% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 11 clinical trials were completed. i.e. 61.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Texas Infectious Diseases Consultants" #1 sponsor was "Gilead Sciences" with 19 trials, followed by "TaiMed Biologics Inc." with 6 trials sponsored, "Pfizer" with 4 trials sponsored, "BioNTech SE" with 3 trials sponsored and "Hoffmann-La Roche" with 3 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Texas Infectious Diseases Consultants" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Westat" with 3 trials as a collaborator and "SIGA Technologies" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "North Texas Infectious Diseases Consultants" are "HIV" (8 trials), "HIV Infections" (8 trials), "HIV-1 Infection" (8 trials), "HIV-1-infection" (8 trials) and "COVID-19" (4 trials). Many other conditions were trialed in "North Texas Infectious Diseases Consultants" in a lesser frequency.

Most popular intervention types in "North Texas Infectious Diseases Consultants" are "Drug" (33 trials), "Biological" (11 trials), "Other" (5 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "B/F/TAF" (8 trials), "E/C/F/TAF" (7 trials), "B/F/TAF Placebo" (3 trials) and "BNT162b2" (3 trials). Other intervention names were less common.

The vast majority of trials in "North Texas Infectious Diseases Consultants" are 43 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "North Texas Infectious Diseases Consultants". undefined are not yet recruiting, 6 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in North Texas Infectious Diseases Consultants, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in North Texas Infectious Diseases Consultants, 5 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".